These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21987585)

  • 1. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases.
    Patel AS; Allen JE; Dicker DT; Peters KL; Sheehan JM; Glantz MJ; El-Deiry WS
    Oncotarget; 2011 Oct; 2(10):752-60. PubMed ID: 21987585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in the cerebrospinal fluid: "tapping" into diagnostic and predictive potential.
    Faltas B
    Oncotarget; 2011 Nov; 2(11):822. PubMed ID: 22064881
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
    Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
    Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system.
    Sölétormos G; Bach F
    Clin Chem Lab Med; 2001 Feb; 39(2):170-2. PubMed ID: 11341753
    [No Abstract]   [Full Text] [Related]  

  • 8. COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation.
    Allen JE; Patel AS; Prabhu VV; Dicker DT; Sheehan JM; Glantz MJ; El-Deiry WS
    Cancer Res; 2014 May; 74(9):2385-90. PubMed ID: 24614081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors.
    Ballester LY; Lu G; Zorofchian S; Vantaku V; Putluri V; Yan Y; Arevalo O; Zhu P; Riascos RF; Sreekumar A; Esquenazi Y; Putluri N; Zhu JJ
    Acta Neuropathol Commun; 2018 Aug; 6(1):85. PubMed ID: 30170631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades.
    Wauters CA; Poelen J; Mulder I; Venderink D; Strobbe LJ; Wesseling P
    J Neurooncol; 2012 May; 107(3):581-9. PubMed ID: 22215233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
    Skerenova M; Mikulova V; Capoun O; Zima T; Tesarova P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):272-280. PubMed ID: 28529342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system metastases from breast carcinoma. A clinical and laboratorial study in 47 patients.
    Machado AB; Machado AA; Barbuto JA; de Oliveira RM
    Arq Neuropsiquiatr; 1998 Jun; 56(2):188-92. PubMed ID: 9698726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cells in the cerebrospinal fluid: a new frontier.
    Burns TF; Wolff AC
    Cell Cycle; 2012 Jan; 11(2):203-4. PubMed ID: 22189717
    [No Abstract]   [Full Text] [Related]  

  • 16. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
    Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
    Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
    Darlix A; Cayrefourcq L; Pouderoux S; Menjot de Champfleur N; Bievelez A; Jacot W; Leaha C; Thezenas S; Alix-Panabières C
    Clin Chem; 2022 Oct; 68(10):1311-1322. PubMed ID: 35953885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
    Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
    J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
    Groves MD; Hess KR; Puduvalli VK; Colman H; Conrad CA; Gilbert MR; Weinberg J; Cristofanilli M; Yung WK; Liu TJ
    J Neurooncol; 2009 Sep; 94(2):229-34. PubMed ID: 19267183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
    Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
    Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.